Platelet-Rich Plasma (PRP) Therapy Vs Minoxidil in Men with Androgenic Alopecia: Systematic Review

Abstract

Androgenic Alopecia is characterized by progressive, patterned hair loss due to excessive sensitivity to androgens in genetically predisposed individuals. It is characterized by the gradual thinning of scalp hair in a specific pattern, causing a significant decrease in the individual's self-esteem and psychological well-being. Currently, there are several therapies for patients with androgenic Alopecia. One of them is platelet-rich plasma (PRP) and Minoxidil. This systematic review aims to compare PRP and minoxidil therapy use in men with androgenic Alopecia. This systematic review was prepared based on the references contained in the Priority Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement. This systematic review was prepared by searching research articles using three databases, namely PubMed, ScienceDirect, and Cochrane. Data was extracted from each study included in this systematic review using a pilot-tested data extraction form. The data that has been collected is then interpreted qualitatively and quantitatively. Based on the six studies reviewed in this systematic review, the majority stated that therapy with PRP on the scalp effectively treats androgenetic Alopecia in men. All studies in this review reveal PRP use's benefits and positive impacts.